Additionally, we conducted a WB assay on the patients’ tumor tissues, which also indicated that the expression of RBM15 and TNFSF9 were drastically upregulated in the PTX-resistant in contrast to the PTX-sensitive group. The gene discussed is RBM15; the disease is neoplasm.